What is Syndax Pharmaceuticals's net investment in lease?

Syndax Pharmaceuticals (SNDX) reported net investment in lease of $1.21M in Q1 2026.

How has Syndax Pharmaceuticals's net investment in lease changed year-over-year?

Syndax Pharmaceuticals's net investment in lease decreased by 32.7% year-over-year, from $1.8M to $1.21M.

What is the long-term trend for Syndax Pharmaceuticals's net investment in lease?

Over 5 years (2020 to 2025), Syndax Pharmaceuticals's net investment in lease has grown at a 35.9% compound annual growth rate (CAGR), from $290K to $1.34M.

Syndax Pharmaceuticals SNDX Net Investment in Lease

Net Investment in Lease at other companies

BiogenBIIB

——

SELLAS Life Sciences Group, Inc.SLS

——

ArriVent BioPharma, Inc.AVBP

——

Viridian Therapeutics, Inc.VRDN

——

Nuvation BioNUVB

——

ImmunomeIMNM

——

Other financials

Income statement

See full

Revenue$64.9M+224%

Operating income-$34.2M+59.2%

Net income-$42.7M+49.7%

EPS (diluted)-$0.48+51.0%

Balance sheet

See full

Cash & equivalents$130.9M-15.0%

Total debt$350.5M+4.2%

Total equity$41.6M-80.6%

Total assets$472.7M-26.2%

Cash flow

See full

Operating cash flow-$50.3M+47.1%

CapEx$46.8K—

Free cash flow-$80.8M-17.6%

Valuation

See full

Market cap$1.74B+95.0%

Enterprise value$1.96B+84.0%

P/S8×-12.4×

Profitability

See full

Operating margin-102.8%-47.8pp

Net margin-111.9%-51.5pp

FCF margin-187.2%-85.4pp

Returns & leverage

See full

Return on equity-189.5%-8,509pp

Debt / equity8.4×+6.9×

Current ratio5.5×-0.3×

Where this comes from

Reported directly by Syndax Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Syndax Pharmaceuticals’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Syndax Pharmaceuticals's net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Syndax Pharmaceuticals's net investment in lease?: Syndax Pharmaceuticals (SNDX) reported net investment in lease of $1.21M in Q1 2026.
How has Syndax Pharmaceuticals's net investment in lease changed year-over-year?: Syndax Pharmaceuticals's net investment in lease decreased by 32.7% year-over-year, from $1.8M to $1.21M.
What is the long-term trend for Syndax Pharmaceuticals's net investment in lease?: Over 5 years (2020 to 2025), Syndax Pharmaceuticals's net investment in lease has grown at a 35.9% compound annual growth rate (CAGR), from $290K to $1.34M.